Cabaletta Bio, Inc.
NASDAQCabaletta Bio heads into its June 9 earnings call with shorts adding sharply, borrow conditions loose, and a high-profile conference drop setting the clinical narrative for the week. Short interest has risen fast and now commands serious attention. It has climbed 17% over the past week to 24.4% of the free float — roughly 23.5 million shares — the highest level recorded in the…
Snapshot as of 3 Jun 2026
Cabaletta Bio heads into its June 9 earnings call with shorts adding sharply, borrow conditions loose, and a high-profile conference drop setting the clinical narrative for the week. Short interest has risen fast and…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CABA — free to start on ORTEX.
Sign up for free →Open CABA on ORTEX